These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 5209849)

  • 21. Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.
    Indrelie JA; Wilson WR; Matsumoto JY; Geraci JE; Washington JA
    Antimicrob Agents Chemother; 1984 Dec; 26(6):909-12. PubMed ID: 6596907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penicillin-resistant Streptococcus viridans.
    Berntsen CA
    N Engl J Med; 1979 Jul; 301(1):51. PubMed ID: 255771
    [No Abstract]   [Full Text] [Related]  

  • 23. Endocarditis due to streptomycin-susceptible Enterococcus faecalis with high-level gentamicin resistance.
    Spiegel CA; Huycke M
    Arch Intern Med; 1989 Aug; 149(8):1873-5. PubMed ID: 2504123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis.
    Matsumoto JY; Wilson WR; Wright AJ; Geraci JE; Washington JA
    Antimicrob Agents Chemother; 1980 Dec; 18(6):944-7. PubMed ID: 7235680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penicillin-netilmicin synergism against Streptococcus faecalis.
    Korzeniowski OM; Wennersten C; Moellering RC; Sande MA
    Antimicrob Agents Chemother; 1978 Mar; 13(3):430-4. PubMed ID: 122522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: Enterococcal endocarditis.
    Portnoy J; Mendelson J
    Can Med Assoc J; 1974 Nov; 111(10):1053-4. PubMed ID: 4429930
    [No Abstract]   [Full Text] [Related]  

  • 27. A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis.
    Moellering RC; Murray BE; Schoenbaum SC; Adler J; Wennersten CB
    J Infect Dis; 1980 Jan; 141(1):81-6. PubMed ID: 6767791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerance and efficacy of parenterally administered penicillin-streptomycin and orally administered amoxicillin or penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.
    Pujadas R; Escriva E; Jane J; Argimon J; Fernandez F; Fava P; Galera M; Garau J
    Antimicrob Agents Chemother; 1990 Feb; 34(2):321-5. PubMed ID: 2109579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies.
    Serra P; Brandimarte C; Martino P; Carlone S; Giunchi G
    Arch Intern Med; 1977 Nov; 137(11):1562-7. PubMed ID: 921443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of enterococcal endocarditis with oral amoxicillin and intramuscular gentamicin.
    Seligman S
    J Infect Dis; 1974 Jun; 129(0):suppl:S213-5. PubMed ID: 4834961
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapy of enterococcal infections.
    Eliopoulos GM; Eliopoulos CT
    Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):118-26. PubMed ID: 2180707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.
    Fernandez-Guerrero M; Rouse MS; Henry NK; Geraci JE; Wilson WR
    Antimicrob Agents Chemother; 1987 Mar; 31(3):430-3. PubMed ID: 3579260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic susceptibility of streptococci and related genera causing endocarditis: analysis of UK reference laboratory referrals, January 1996 to March 2000.
    Johnson AP; Warner M; Broughton K; James D; Efsratiou A; George RC; Livermore DM
    BMJ; 2001 Feb; 322(7283):395-6. PubMed ID: 11179156
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibiotic combinations synergic for enterococci.
    Serra P; Brandimarte C; Martino P
    Antibiotica; 1972; 10(1-2):22-32. PubMed ID: 4679551
    [No Abstract]   [Full Text] [Related]  

  • 35. Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci.
    Moellering RC; Watson BK; Kunz LJ
    Am J Med; 1974 Aug; 57(2):239-50. PubMed ID: 4843895
    [No Abstract]   [Full Text] [Related]  

  • 36. Bactericidal activity of combinations of gentamicin with penicillin or clindamycin against Streptococcus mutans.
    Snyder RJ; Wilkowske CJ; Washington JA
    Antimicrob Agents Chemother; 1975 Mar; 7(3):333-5. PubMed ID: 1137387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bactericidal activity of netilmicin compared with gentamicin and streptomycin, alone and in combination with penicillin, against penicillin tolerant viridans streptococci and enterococci.
    Shanson DC; Tadayon M; Bakhtiar M
    J Antimicrob Chemother; 1986 Oct; 18(4):479-90. PubMed ID: 3095305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Group D streptococcal bacteremia, with emphasis on the incidence and presentation of infections due to Streptococcus bovis.
    Ravreby WD; Bottone EJ; Keusch GT
    N Engl J Med; 1973 Dec; 289(26):1400-3. PubMed ID: 4753940
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of protein binding on the activity of penicillins in combination with gentamicin against enterococci.
    Glew RH; Moellering RC
    Antimicrob Agents Chemother; 1979 Jan; 15(1):87-92. PubMed ID: 426508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative bactericidal activity of penicillin-netilmicin and penicillin-gentamicin against enterococci.
    Rahal JJ; Simberkoff MS
    J Antimicrob Chemother; 1986 May; 17(5):585-91. PubMed ID: 3636323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.